WolfDYauCvan 't VeerL2021Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2-positive breast cancer in the adaptively randomized I-SPY2 trialNCBI Gene Expression OmnibusGSE181574. The gene discussed is ERBB2; the disease is breast carcinoma.